Status:

COMPLETED

Clinical Study to Compare Visual Performance of Two Trifocal IOLs

Lead Sponsor:

Beaver-Visitec International, Inc.

Conditions:

Cataract

Lens Opacities

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

Prospective, randomised, controlled, single-surgeon, single-center post-market clinical follow up study to compare the clinical outcomes of two trifocal IOLs with different material

Detailed Description

This is a prospective, randomised, controlled, single-surgeon, single-center post-market clinical follow up study whereby patients undergoing routine cataract surgery will have bilateral implantation ...

Eligibility Criteria

Inclusion

  • Cataractous eyes with no comorbidity
  • Spontaneously emitting the desire for spectacle independence after surgery and with realistic expectation.
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent

Exclusion

  • Irregular astigmatism
  • Age of patient \< 50 years
  • Regular corneal astigmatism \>1.00 dioptres by an automatic keratometer or biometer or \>1.25 dioptres if the steep axis of cylinder is between 90° and 120° in one or both eyes
  • Difficulty for cooperation (distance from their home, general health condition)
  • Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)
  • Any ocular comorbidity
  • History of ocular trauma or prior ocular surgery including refractive procedures
  • Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)
  • Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
  • AMD suspicious eyes (determined by OCT)
  • Complicated surgery

Key Trial Info

Start Date :

October 2 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 21 2019

Estimated Enrollment :

53 Patients enrolled

Trial Details

Trial ID

NCT03347981

Start Date

October 2 2017

End Date

May 21 2019

Last Update

May 6 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Innova Ocular IOA Madrid

Madrid, Spain, 28003